Extramedullary plasmacytoma with a t(11;14)(q13;q32) and aggressive clinical course

被引：2
|
作者：
Parkins, Elizabeth [2 ]
Boll, Maayke [1 ]
O'Connor, Sheila J. M. [1 ]
Rawstron, Andy C. [1 ]
Owen, Roger G. [1 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, HMDS Lab, Leeds, W Yorkshire, England
[2] Royal Cornwall Hosp NHS Trust, Truro, England
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 07期
关键词：
MULTIPLE-MYELOMA; NETWORK;
D O I：
10.3109/10428194.2010.486454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1360 / 1362
页数：3
相关论文
共 50 条
  • [41] Neoplastic plasma cells mimic mature neutrophils in plasma cell myeloma with t(11;14)(q13;q32)
    不详
    BLOOD, 2015, 125 (18) : 2875 - 2875
  • [42] Myeloma (MM) and the t(11;14)(q13;q32); Increasing evidence for a biologically distinct subset of patients.
    Fonseca, R
    Harrington, D
    Oken, MM
    Hoyer, JD
    Dewald, GW
    Bailey, RJ
    Van Wier, SA
    Henderson, KJ
    Kay, NE
    van Ness, B
    Blood, EA
    Greipp, PR
    BLOOD, 2000, 96 (11) : 151A - 151A
  • [43] Cytogenetics in multiple myeloma:: A multicenter study of 24 patients with t(11;14)(q13;q32) or its variant
    Laï, JL
    Michaux, L
    Dastugue, N
    Vasseur, F
    Daudignon, A
    Facon, T
    Bauters, F
    Zandecki, M
    CANCER GENETICS AND CYTOGENETICS, 1998, 104 (02) : 133 - 138
  • [44] GENE REARRANGEMENT AND OVEREXPRESSION OF PRAD1 IN LYMPHOID MALIGNANCY WITH T(11/14)(Q13/Q32) TRANSLOCATION
    SETO, M
    YAMAMOTO, K
    IIDA, S
    AKAO, Y
    UTSUMI, KR
    KUBONISHI, I
    MIYOSHI, I
    OHTSUKI, T
    YAWATA, Y
    NAMBA, M
    MOTOKURA, T
    ARNOLD, A
    TAKAHASHI, T
    UEDA, R
    ONCOGENE, 1992, 7 (07) : 1401 - 1406
  • [45] Cytogenetics in multiple myeloma: A multicentre study of 24 patients with t(11;14) (q13;q32) or variant.
    Lai, JL
    Michaux, L
    Dastugue, N
    Daudignon, A
    Vasseur, F
    Zandecki, M
    Bauters, F
    Facon, T
    BLOOD, 1996, 88 (10) : 1542 - 1542
  • [46] Value of interphase FISH for the diagnosis of t(11;14)(q13;q32) on skin lesions of mantle cell lymphoma
    Dubus, P
    Young, P
    Beylot-Barry, M
    Belaud-Rotureau, MA
    Courville, P
    Vergier, B
    Parrens, M
    Lenormand, B
    Joly, P
    Merlio, JP
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (06) : 832 - 841
  • [47] BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders
    Michaux, L
    Mecucci, C
    Stul, M
    Wlodarska, I
    Hernandez, JM
    Meeus, P
    Michaux, JL
    Scheiff, JM
    Noel, H
    Louwagie, A
    Criel, A
    Boogaerts, M
    VanOrshoven, A
    Cassiman, JJ
    VandenBerghe, H
    GENES CHROMOSOMES & CANCER, 1996, 15 (01): : 38 - 47
  • [48] Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32) and - 17p13 (p53) deletions in myeloma patients treated with high dose therapy
    Gertz, MA
    Lacy, MQ
    Dispenzieri, A
    Greipp, PR
    Litzow, MR
    Henderson, KJ
    Van Wier, SA
    Ahmann, GJ
    Fonseca, R
    BLOOD, 2004, 104 (11) : 99A - 99A
  • [49] MOLECULAR MAPPING OF THE CHROMOSOME-II BREAKPOINT OF T(11 17)(Q13 Q21) IN A T(11 14)(Q13 Q32)-POSITIVE-B NON-HODGKINS-LYMPHOMA
    WLODARSKA, I
    SCHOENMAKERS, E
    KAS, K
    MERREGAERT, J
    LEMAHIEU, V
    WEIER, U
    VANDENBERGHE, H
    VANDEVEN, WJM
    GENES CHROMOSOMES & CANCER, 1993, 8 (04): : 224 - 229
  • [50] The clinical significance of the t(11;14) (q13;q32) translocation detected by FISH in the bone marrow of patients with mantle cell lymphoma in remission
    Cao, SN
    Caraway, NP
    Albitar, M
    Jilani, IB
    Gu, J
    Zaidi, T
    Romaguera, JE
    Katz, RL
    MODERN PATHOLOGY, 2003, 16 (01) : 227A - 227A
12345